-In patients with symptomatic peripheral artery disease (PAD) with a history of limb revascularization, the optimal antithrombotic regimen for long-term management is unknown.
Ticagrelor Compared With Clopidogrel in Patients with Prior Lower Extremity Revascularization for Peripheral Artery Disease / Jones, W.S., Baumgartner, I., Hiatt, W.R., Heizer, G., Conte, M.S., White, C.J., Berger, J.S., Held, P., Katona, B.G., Mahaffey, K.W., Norgren, L., Blomster, J., Millegård, M., Reist, C., Patel, M.R., Fowkes, G.R.o.b.o.t.I.S.C., Amato, B.. - In: CIRCULATION. - ISSN 0009-7322. - 135:3(2017), pp. CIRCULATIONAHA.116.025880-250. [10.1161/CIRCULATIONAHA.116.025880]
Ticagrelor Compared With Clopidogrel in Patients with Prior Lower Extremity Revascularization for Peripheral Artery Disease
Investigators of the EUCLID Trial
2017
Abstract
-In patients with symptomatic peripheral artery disease (PAD) with a history of limb revascularization, the optimal antithrombotic regimen for long-term management is unknown.| File | Dimensione | Formato | |
|---|---|---|---|
|
CIRCULATIONAHA.116.025880.full.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
3.06 MB
Formato
Adobe PDF
|
3.06 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
